Year |
Citation |
Score |
2020 |
Lewis EMA, Sankar S, Tong C, Patterson E, Waller LE, Gontarz P, Zhang B, Ornitz DM, Kroll KL. Geminin is required for Hox gene regulation to pattern the developing limb. Developmental Biology. PMID 32450229 DOI: 10.1016/J.Ydbio.2020.05.007 |
0.719 |
|
2017 |
Sankar S, Patterson E, Lewis EM, Waller LE, Tong C, Dearborn J, Wozniak D, Rubin JB, Kroll KL. Geminin deficiency enhances survival in a murine medulloblastoma model by inducing apoptosis of preneoplastic granule neuron precursors. Genes & Cancer. 8: 725-744. PMID 29234490 DOI: 10.18632/genesandcancer.157 |
0.699 |
|
2017 |
Zhang B, Madden P, Gu J, Xing X, Sankar S, Flynn J, Kroll K, Wang T. Uncovering the transcriptomic and epigenomic landscape of nicotinic receptor genes in non-neuronal tissues. Bmc Genomics. 18: 439. PMID 28583088 DOI: 10.1186/s12864-017-3813-4 |
0.649 |
|
2016 |
Sankar S, Yellajoshyula D, Zhang B, Teets B, Rockweiler N, Kroll KL. Gene regulatory networks in neural cell fate acquisition from genome-wide chromatin association of Geminin and Zic1. Scientific Reports. 6: 37412. PMID 27881878 DOI: 10.1038/srep37412 |
0.6 |
|
2016 |
Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, Lessnick SL. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene. PMID 27345405 DOI: 10.1038/onc.2016.142 |
0.63 |
|
2016 |
Osgood CL, Maloney N, Kidd CG, Kitchen-Goosen SM, Segars LE, Gebregiorgis M, Woldemichael GM, He M, Sankar S, Lessnick SL, Kang MH, Smith MA, Turner L, Madaj ZB, Winn ME, et al. Identification of mithramycin analogs with improved targeting of the EWS-FLI1 transcription factor. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26979396 DOI: 10.1158/1078-0432.Ccr-15-2624 |
0.61 |
|
2014 |
Zhuo R, Kosak KM, Sankar S, Wiles ET, Sun Y, Zhang J, Ayello J, Prestwich GD, Shami PJ, Cairo MS, Lessnick SL, Luo W. Targeting Glutathione S-transferase M4 in Ewing sarcoma. Frontiers in Pediatrics. 2: 83. PMID 25147782 DOI: 10.3389/Fped.2014.00083 |
0.641 |
|
2014 |
Sankar S, Theisen ER, Bearss J, Mulvihill T, Hoffman LM, Sorna V, Beckerle MC, Sharma S, Lessnick SL. Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4584-97. PMID 24963049 DOI: 10.1158/1078-0432.Ccr-14-0072 |
0.644 |
|
2014 |
Zhuo R, Kosak KM, Sankar S, Wiles ET, Sun Y, Zhang J, Prestwich GD, Shami PJ, Lessnick SL, Cairo MS, Luo W. Abstract 3965: Modulating glutathione s-transferase M4 activity for the treatment of Ewing sarcoma Cancer Research. 74: 3965-3965. DOI: 10.1158/1538-7445.Am2014-3965 |
0.386 |
|
2014 |
Theisen ER, Sankar S, Bearss J, Mulvihill T, Sorna V, Sharma S, Lessnick SL. Abstract 3679: Inhibition of LSD1 disrupts global EWS/ETS transcriptional function in Ewing sarcoma Cancer Research. 74: 3679-3679. DOI: 10.1158/1538-7445.Am2014-3679 |
0.503 |
|
2013 |
Sankar S, Gomez NC, Bell R, Patel M, Davis IJ, Lessnick SL, Luo W. EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in Ewing Sarcoma. Genes & Cancer. 4: 213-23. PMID 24069508 DOI: 10.1177/1947601913489569 |
0.712 |
|
2013 |
Sankar S, Tanner JM, Bell R, Chaturvedi A, Randall RL, Beckerle MC, Lessnick SL. A novel role for keratin 17 in coordinating oncogenic transformation and cellular adhesion in Ewing sarcoma. Molecular and Cellular Biology. 33: 4448-60. PMID 24043308 DOI: 10.1128/Mcb.00241-13 |
0.644 |
|
2013 |
Sankar S, Bell R, Stephens B, Zhuo R, Sharma S, Bearss DJ, Lessnick SL. Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene. 32: 5089-100. PMID 23178492 DOI: 10.1038/Onc.2012.525 |
0.706 |
|
2012 |
Sankar S, Lessnick SL. Abstract 2219: Mechanism of trancriptional repression by EWS/FLI in Ewing's sarcoma Cancer Research. 72: 2219-2219. DOI: 10.1158/1538-7445.Am2012-2219 |
0.542 |
|
2011 |
Sankar S, Lessnick SL. Promiscuous partnerships in Ewing's sarcoma. Cancer Genetics. 204: 351-65. PMID 21872822 DOI: 10.1016/J.Cancergen.2011.07.008 |
0.63 |
|
2009 |
Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance. Oncogene. 28: 4126-32. PMID 19718047 DOI: 10.1038/Onc.2009.262 |
0.692 |
|
2008 |
Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, Shah AA, Boucher KM, Watkins WS, Jorde LB, Graves BJ, Lessnick SL. Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proceedings of the National Academy of Sciences of the United States of America. 105: 10149-54. PMID 18626011 DOI: 10.1073/Pnas.0801073105 |
0.706 |
|
Show low-probability matches. |